Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nolato AB's total equity for the quarter that ended in Jun. 2026 was kr5,675 Mil.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
Nolato AB Total Equity Related Terms
Nolato AB Total Equity Historical Data
* Premium members only.
The historical data trend for Nolato AB's Total Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nolato AB (CHIX:NOLABS) has a Total Equity of kr5,675 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Nolato AB and its competitors.
Is Nolato AB's Total Equity too high?
Nolato AB's current Total Equity is kr5,675 Mil. Overall, Nolato AB has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's Total Equity compare to ABT and SYK?
Nolato AB's Total Equity of kr5,675 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Nolato AB and its competitors. Nolato AB's current Total Equity is kr5,675 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Nolato AB (CHIX:NOLABS) has a current Total Equity of kr5,675 Mil. The stock's GF Value™ is kr55.60, compared to a current price of kr48.88 — trading 12.1% below its estimated fair value. The current Total Equity is kr5,675 Mil. Nolato AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Nolato AB (CHIX:NOLABS), the current Total Equity is kr5,675 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (CHIX:NOLABS) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of kr48.88 is trading 12.1% below its estimated GF Value™ of kr55.60.
Key valuation signals for CHIX:NOLABS:
Total Equity: kr5,675 Mil
GF Value™: kr55.60 vs. price of kr48.88 (12.1% below fair value)
No single metric tells the full story. See the CHIX:NOLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
76GF Score
Get the complete analysis for CHIX:NOLABS
Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:NOLABS has been successfully added to your 
